Paper · 10072558
Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis.
Kim HJ and 3 others. J Immunol, 1999. Cited by 159 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. Papers, record 10072558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10072558
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Reactive | Major topic |
| Arthritis, Rheumatoid | Major topic |
| Germinal Center | Major topic |
| Plasma Cells | Major topic |
| Synovial Membrane | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Antigens, CD20 | |
| Female | |
| Humans | |
| Immunoglobulin Heavy Chains | |
| Immunoglobulin Variable Region | |
| Male | |
| Middle Aged |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,829,741 | Deep topic modeling of spatial transcriptomics in the rheumatoid arthritis synovium identifies distinct classes of ectopic lymphoid structures. | bioRxiv | 2025 | https://conductscience.org/library/papers/39829741 | PubMed |
| 39,055,820 | Immunophenotypic Landscape of synovial tissue in rheumatoid arthritis: Insights from ACPA status. | Heliyon | 2024 | https://conductscience.org/library/papers/39055820 | PubMed |
| 38,919,260 | Deciphering the therapeutic potential of trimetazidine in rheumatoid arthritis via targeting mi-RNA128a, TLR4 signaling pathway, and adenosine-induced FADD-microvesicular shedding: In vivo and in silico study. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38919260 | PubMed |
| 38,914,737 | Deciphering Autoimmune Diseases: Unveiling the Diagnostic, Therapeutic, and Prognostic Potential of Immune Repertoire Sequencing. | Inflammation | 2025 | https://conductscience.org/library/papers/38914737 | PubMed |
| 38,361,928 | Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma. | Front Immunol | 2024 | https://conductscience.org/library/papers/38361928 | PubMed |
| 37,171,806 | The Plasma Cell Infiltrate Populating the Muscle Tissue of Patients with Inclusion Body Myositis Features Distinct B Cell Receptor Repertoire Properties. | Immunohorizons | 2023 | https://conductscience.org/library/papers/37171806 | PubMed |
| 35,064,306 | CD30-targeted therapy induces apoptosis of inflammatory cytokine-stimulated synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice. | Inflamm Res | 2022 | https://conductscience.org/library/papers/35064306 | PubMed |
| 34,638,855 | The Germinal Center Milieu in Rheumatoid Arthritis: The Immunological Drummer or Dancer? | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638855 | PubMed |
| 34,623,901 | Integrated single-cell transcriptomics and epigenomics reveals strong germinal center-associated etiology of autoimmune risk loci. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34623901 | PubMed |
| 33,784,344 | Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis. | PLoS One | 2021 | https://conductscience.org/library/papers/33784344 | PubMed |
1 to 10 of 66
See all 66 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| KRT20 | 54,474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
| MLC1 | 23,209 | PubTator's text mining | https://conductscience.org/library/genes/23209 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10072558
GET https://conductscience.org/api/papers/v1/10072558/cited_by?page=2